09 June 2021>: Articles
Challenges in the Management of an Adult Snakebite Victim at a Tertiary Care Hospital: A Case Report
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)
Ahmed Abdeldayem A* , Alhanouf Ayed Alanazi B , Jawaher N. Aljabri B , Ijaz Abid BDOI: 10.12659/AJCR.931532
Am J Case Rep 2021; 22:e931532
Table 1. Blood coagulation profile throughout admission.
Day | Test name (reference value) | ||||
---|---|---|---|---|---|
INR (0.80–1.20) | PT (11.0–14.5) s | PTT (26.1–37.3) s | D-dimer (0.00–0.50) mg/L FEU | Fibrinogen (1.50–4.10) gm/L | |
Day 1 | 1.02 | 12.5 | 27.9 | ||
Day 2 | >11.0 | >180 | >180 | Undetectable | |
Day 3 | |||||
Day 4 | 1.41 | 17 | 30.2 | >35.00 | 0.3 |
Day 5 | 1.99 | 23.4 | 30.2 | 27.96 | 0.3 |
Day 6 | |||||
Day 7 | |||||
Day 8 Post-discharge | 1.03 | 12.7 | 24.2 | 1.65 | 1.19 |
Day 11 Post-discharge | 0.99 | 12.2 | 25.4 | 0.71 | 2.1 |
a First ASV dose (subtherapeutic); b Second ASV dose (Full), 6 units of cryoprecipitate, and 6 units of plasma; c Third ASV dose (Full); d Fourth ASV dose (Full). * Lab values after ASV doses on previous day. ASV – anti-snake venom; INR – international normalized ratio; PT – prothrombin time; PTT – partial thromboplastin time. |